Biosimilars Market Report

Europe Biosimilars Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 22, 2020
  • PAGES：199
  • REPORT CODE：GMM579827
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.

    The Biosimilars market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Biosimilars Market Segmentations:

    By Player:

    • Merck KGaA

    • Celltrion

    • Hospira

    • Sandoz International

    • Roche Diagnostics

    • Mylan

    • Teva Pharmaceutical

    • Biocon

    • Amgen

    By Type:

    • Injection

    • Tablets

    • Others

    By End-User:

    • Ankylosing Spondylitis

    • Tumor

    • Rheumatoid Arthrtis

    • Cardiovascular

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026

    • 1.3.2 Europe Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026

    • 1.3.3 Europe Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026

    • 1.4.2 Europe Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • 1.4.3 Europe Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026

    • 1.4.4 Europe Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilars by Major Types

      • 3.4.1 Market Size and Growth Rate of Injection

      • 3.4.2 Market Size and Growth Rate of Tablets

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Ankylosing Spondylitis for Construction

      • 4.4.2 Market Size and Growth Rate of Tumor for Construction

      • 4.4.3 Market Size and Growth Rate of Rheumatoid Arthrtis for Construction

      • 4.4.4 Market Size and Growth Rate of Cardiovascular for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Biosimilars Production Analysis by Top Regions

    • 5.2 Europe Biosimilars Consumption Analysis by Top Regions

    • 5.3 Europe Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 France Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biosimilars Market among Top Countries

    • 6.1 Top 5 Export Countries in Biosimilars Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biosimilars Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biosimilars Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biosimilars Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biosimilars Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biosimilars Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Biosimilars Landscape Analysis

    • 7.1 Germany Biosimilars Landscape Analysis by Major Types

    • 7.2 Germany Biosimilars Landscape Analysis by Major End-Users

    8. UK Biosimilars Landscape Analysis

    • 8.1 UK Biosimilars Landscape Analysis by Major Types

    • 8.2 UK Biosimilars Landscape Analysis by Major End-Users

    9. France Biosimilars Landscape Analysis

    • 9.1 France Biosimilars Landscape Analysis by Major Types

    • 9.2 France Biosimilars Landscape Analysis by Major End-Users

    10. Italy Biosimilars Landscape Analysis

    • 10.1 Italy Biosimilars Landscape Analysis by Major Types

    • 10.2 Italy Biosimilars Landscape Analysis by Major End-Users

    11. Spain Biosimilars Landscape Analysis

    • 11.1 Spain Biosimilars Landscape Analysis by Major Types

    • 11.2 Spain Biosimilars Landscape Analysis by Major End-Users

    12. Poland Biosimilars Landscape Analysis

    • 12.1 Poland Biosimilars Landscape Analysis by Major Types

    • 12.2 Poland Biosimilars Landscape Analysis by Major End-Users

    13. Russia Biosimilars Landscape Analysis

    • 13.1 Russia Biosimilars Landscape Analysis by Major Types

    • 13.2 Russia Biosimilars Landscape Analysis by Major End-Users

    14. Switzerland Biosimilars Landscape Analysis

    • 14.1 Switzerland Biosimilars Landscape Analysis by Major Types

    • 14.2 Switzerland Biosimilars Landscape Analysis by Major End-Users

    15. Turkey Biosimilars Landscape Analysis

    • 15.1 Turkey Biosimilars Landscape Analysis by Major Types

    • 15.2 Turkey Biosimilars Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Landscape Analysis by Top Countries

      • 16.3.1 Denmark Biosimilars Market Volume and Growth Rate

      • 16.3.2 Finland Biosimilars Market Volume and Growth Rate

      • 16.3.3 Norway Biosimilars Market Volume and Growth Rate

      • 16.3.4 Sweden Biosimilars Market Volume and Growth Rate

      • 16.3.6 Iceland Biosimilars Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Landscape Analysis by Top Countries

      • 17.3.1 Belgium Biosimilars Market Volume and Growth Rate

      • 17.3.2 Netherlands Biosimilars Market Volume and Growth Rate

      • 17.3.3 Luxembourg Biosimilars Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Landscape Analysis by Top Countries

      • 18.3.1 Estonia Biosimilars Market Volume and Growth Rate

      • 18.3.2 Latvia Biosimilars Market Volume and Growth Rate

      • 18.3.3 Lithuania Biosimilars Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merck KGaA

      • 19.1.1 Merck KGaA Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Celltrion

      • 19.2.1 Celltrion Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Hospira

      • 19.3.1 Hospira Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sandoz International

      • 19.4.1 Sandoz International Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Roche Diagnostics

      • 19.5.1 Roche Diagnostics Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Mylan

      • 19.6.1 Mylan Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Teva Pharmaceutical

      • 19.7.1 Teva Pharmaceutical Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Biocon

      • 19.8.1 Biocon Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Amgen

      • 19.9.1 Amgen Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 109 Figures and 196 Tables)

    • Figure Product Picture

    • Figure Biosimilars Market Size and Growth Rate of Injection Market, 2015 - 2026 (USD Million)

    • Figure Biosimilars Market Size and Growth Rate of Tablets Market, 2015 - 2026 (USD Million)

    • Figure Biosimilars Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Germany Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure France Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different Types from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Injection Market, 2015 - 2026 (USD Million)

    • Figure Biosimilars Market Size and Growth Rate of Tablets Market, 2015 - 2026 (USD Million)

    • Figure Biosimilars Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different End-Users from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026

    • Figure Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Table Europe Biosimilars Production by Major Regions

    • Table Europe Biosimilars Production Share by Major Regions

    • Figure Europe Biosimilars Production Share by Major Countries and Regions in 2014

    • Table Europe Biosimilars Consumption by Major Regions

    • Table Europe Biosimilars Consumption Share by Major Regions

    • Table Germany Biosimilars Production, Import, Consumption and Export Analysis

    • Table UK Biosimilars Production, Import, Consumption and Export Analysis

    • Table France Biosimilars Production, Import, Consumption and Export Analysis

    • Table Italy Biosimilars Production, Import, Consumption and Export Analysis

    • Table Spain Biosimilars Production, Import, Consumption and Export Analysis

    • Table Poland Biosimilars Production, Import, Consumption and Export Analysis

    • Table Russia Biosimilars Production, Import, Consumption and Export Analysis

    • Table Switzerland Biosimilars Production, Import, Consumption and Export Analysis

    • Table Turkey Biosimilars Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biosimilars Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Biosimilars Consumption by Types from 2014 to 2026

    • Table Germany Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Germany Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Germany Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table UK Biosimilars Consumption by Types from 2014 to 2026

    • Table UK Biosimilars Consumption Share by Types from 2014 to 2026

    • Table UK Biosimilars Consumption by End-Users from 2014 to 2026

    • Table UK Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table France Biosimilars Consumption by Types from 2014 to 2026

    • Table France Biosimilars Consumption Share by Types from 2014 to 2026

    • Table France Biosimilars Consumption by End-Users from 2014 to 2026

    • Table France Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Italy Biosimilars Consumption by Types from 2014 to 2026

    • Table Italy Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Italy Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Italy Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Spain Biosimilars Consumption by Types from 2014 to 2026

    • Table Spain Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Spain Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Spain Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Poland Biosimilars Consumption by Types from 2014 to 2026

    • Table Poland Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Poland Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Poland Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Russia Biosimilars Consumption by Types from 2014 to 2026

    • Table Russia Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Russia Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Russia Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Biosimilars Consumption by Types from 2014 to 2026

    • Table Switzerland Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Switzerland Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Switzerland Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Biosimilars Consumption by Types from 2014 to 2026

    • Table Turkey Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Turkey Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Turkey Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Merck KGaA Profiles

    • Table Merck KGaA Production, Value, Price, Gross Margin 2014-2019

    • Table Merck KGaA Product benchmarking

    • Table Merck KGaA Strategic initiatives

    • Table Merck KGaA SWOT analysis

    • Table Celltrion Profiles

    • Table Celltrion Production, Value, Price, Gross Margin 2014-2019

    • Table Celltrion Product benchmarking

    • Table Celltrion Strategic initiatives

    • Table Celltrion SWOT analysis

    • Table Hospira Profiles

    • Table Hospira Production, Value, Price, Gross Margin 2014-2019

    • Table Hospira Product benchmarking

    • Table Hospira Strategic initiatives

    • Table Hospira SWOT analysis

    • Table Sandoz International Profiles

    • Table Sandoz International Production, Value, Price, Gross Margin 2014-2019

    • Table Sandoz International Product benchmarking

    • Table Sandoz International Strategic initiatives

    • Table Sandoz International SWOT analysis

    • Table Roche Diagnostics Profiles

    • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Diagnostics Product benchmarking

    • Table Roche Diagnostics Strategic initiatives

    • Table Roche Diagnostics SWOT analysis

    • Table Mylan Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Mylan Product benchmarking

    • Table Mylan Strategic initiatives

    • Table Mylan SWOT analysis

    • Table Teva Pharmaceutical Profiles

    • Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Teva Pharmaceutical Product benchmarking

    • Table Teva Pharmaceutical Strategic initiatives

    • Table Teva Pharmaceutical SWOT analysis

    • Table Biocon Profiles

    • Table Biocon Production, Value, Price, Gross Margin 2014-2019

    • Table Biocon Product benchmarking

    • Table Biocon Strategic initiatives

    • Table Biocon SWOT analysis

    • Table Amgen Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Amgen Product benchmarking

    • Table Amgen Strategic initiatives

    • Table Amgen SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US